Canopy Growth Corp (CGC) stock
CGCNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends March 31
$0.53−0.01 (-2.67%)
Close on Nov 17, 2026Market cap $224.80MP/E –Yield –
Canopy Growth price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Canopy Growth's price to sales ratio was 1.2× on Nov 11, 2026, against 2.0× a year earlier. Over the last 5 years it ranged from 0.6× to 7.6×, with a median of 1.9×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.2× | −0.6 |
| 2025 | Dec 31, 2025 | 1.9× | +0.5 |
| 2024 | Dec 31, 2024 | 1.3× | +0.1 |
| 2023 | Dec 29, 2023 | 1.3× | −1.8 |
| 2022 | Dec 30, 2022 | 3.1× | −4.5 |
| 2021 | Dec 31, 2021 | 7.6× | −16.0 |
| 2020 | Dec 31, 2020 | 23.6× | −130.7 |
| 2019 | Apr 30, 2019 | 154.3× | +70.9 |
| 2018 | Dec 31, 2018 | 83.4× | −4.9 |
| 2017 | Dec 29, 2017 | 88.3× | – |
See a number that looks wrong?